Name: The Biotech Age: The Business of Biotech and how to Profit From it (en Inglés)
Price: 26120.00 CLP
Availability: InStock
Author: Richard Oliver
ISBN: 9780071414890

portada The Biotech Age: The Business of Biotech and how to Profit From it (en Inglés)

Formato

Libro Físico

Editorial

Mcgraw-Hill Companies

Autor

Richard Oliver

Año

2003

Idioma

Inglés

N° páginas

253

Encuadernación

Tapa Blanda

ISBN

0071414894

ISBN13

9780071414890

N° edición

Categorías

Industria y estudios industriales

The Biotech Age: The Business of Biotech and how to Profit From it (en Inglés)

Richard Oliver (Autor) · Mcgraw-Hill Companies · Tapa Blanda

Libro Nuevo

$ 26.120

$ 43.540

Ahorras: $ 17.420

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 27 de Mayo y el Jueves 06 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "The Biotech Age: The Business of Biotech and how to Profit From it (en Inglés)"

A look at the forefront of an industry revolution ""I've been deep inside the biotech industry since its infancy. This book provides fresh insights about how it started, what drives it, and most importantly, where it's going.""--Scott W. Morrison, partner, Ernst & Young LL Richard W. Oliver predicted the onset of a new era with The Coming Biotech Age. Now that age is here--and companies are reaping the benefits of this incredible new revolution. As biotech companies become the new economic engines of growth and innovation, businesses must have access to the latest developments of this area of research. In a special revised edition, now titled The Biotech Age, Oliver has created the first practical guide to this fascinating realm of scientific development. With updated information on the latest research, examples of biotech breakthroughs, and a close examination of current biotech issues such as cloning and stem cell research, The Biotech Age presents an accessible overview of the business of biotechnology and its vast implications and opportunities for all types of industries. This is a topic no one can afford to miss--especially future-minded executives and investors in cutting-edge technologies.